Testing effectiveness (Phase 2)Study completedNCT00150982What this trial is testingAlefacept Mechanism of Action in PsoriasisWho this might be right forPsoriasis University of Medicine and Dentistry of New Jersey 9
Post-approval studies (Phase 4)WithdrawnNCT02558361What this trial is testingTreatment With Apremilast in Patients With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis University of South Florida
Large-scale testing (Phase 3)Study completedNCT02181673What this trial is testingGolimumab in Participants With Active Psoriatic ArthritisWho this might be right forArthritis, Psoriatic Janssen Research & Development, LLC 480
Not applicableNot Yet RecruitingNCT07336641What this trial is testingLANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical PracticeWho this might be right forPsoriasisAtopic DermatitisVitiligo+2 more Fondazione ISIDE 20,000
Large-scale testing (Phase 3)Study completedNCT04167462What this trial is testingAn Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South KoreaWho this might be right forPsoriasis Bristol-Myers Squibb 220
Not applicableUnknownNCT04750161What this trial is testingThe Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin DisordersWho this might be right forPsoriasis VulgarisAtopic DermatitisIchthyosis Vulgaris St. James's Hospital, Ireland 80
Not applicableUnknownNCT03526705What this trial is testingThe Effect of NB-UVB on Interleukin-36 Levels in PsoriasisWho this might be right forPsoriasis Cairo University 25
Not applicableStudy completedNCT02752672What this trial is testingStudy on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque PsoriasisWho this might be right forPsoriasis Medical University of Graz 27
Not applicableStudy completedNCT02162472What this trial is testingVideocapillaroscopy Assessment During Systemic Agent Therapy in PsoriasisWho this might be right forPsoriasis Northwestern University 19
Testing effectiveness (Phase 2)Looking for participantsNCT07801495What this trial is testingAssess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic ArthritisWho this might be right forModerate to Severe Psoriatic Arthritis Novartis Pharmaceuticals 220
Early research (Phase 1)Study completedNCT05514353What this trial is testingAssess Single and Multiple Ascending Doses of PBI-100 Topical CreamWho this might be right forHealthy VolunteersPsoriasis Pyramid Biosciences 32
Early research (Phase 1)Study completedNCT03733353What this trial is testingEDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic DermatitisWho this might be right forPsoriasisAtopic Dermatitis Evelo Biosciences, Inc. 204
Large-scale testing (Phase 3)Study completedNCT03168256What this trial is testingCF101 Therapy in Patients With Moderate-to-severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Can-Fite BioPharma 528
Large-scale testing (Phase 3)Study completedNCT02905331What this trial is testingEfficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 78
Testing effectiveness (Phase 2)Study completedNCT03630939What this trial is testingEvaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque PsoriasisWho this might be right forPsoriatic Plaque Escalier Biosciences B.V. 104
Not applicableLooking for participantsNCT07693595What this trial is testingNailfold Capillaroscopic Changes in PsoriasisWho this might be right forPsoriasis Al-Azhar University 100
Large-scale testing (Phase 3)Study completedNCT00258713What this trial is testingA 36-Week Extension to Protocol ISA04-03Who this might be right forPsoriasis Aurinia Pharmaceuticals Inc. 309
Post-approval studies (Phase 4)Study completedNCT03406117What this trial is testingDetermine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch TestsWho this might be right forHealthyAtopic DermatitisPsoriasis Haus Bioceuticals 182
Early research (Phase 1)Study completedNCT02529956What this trial is testingAssess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With PsoriasisWho this might be right forMild to Moderate Psoriasis UCB Celltech 39
Not applicableLooking for participantsNCT07648602What this trial is testingPPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional StudyWho this might be right forPsoriasis CorEvitas 2,500